Inventor · disambiguated record
Matthias Grell
Also filed as: GRELL MATTHIAS
9 granted patents·21 pending applications·80 citations·filing 2001–2013
85Inventor score
Top patents by PatentIndex Score
30 records- 0187US7691870B2Benzimidazole carboxamides as raf kinase inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Apr 6, 2010·30 cites·8 claims
- 0284US7368295B2Nanoparticles comprising biologically active TNF which is immobilized on the sameFRAUNHOFER GES FORSCHUNG·Filed 2002·Granted May 6, 2008·30 cites·67 claims
- 0378US7589112B2Methylene urea derivativesMERCK PATENT GMBH·Filed 2003·Granted Sep 15, 2009·9 cites·4 claims
- 0473US7598274B2Pyrrole derivativesMERCK PATENT GMBH·Filed 2004·Granted Oct 6, 2009·7 cites·24 claims
- 0571US8410143B2Methylene urea derivativesBUCHSTALLER HANS-PETER·Filed 2009·Granted Apr 2, 2013·1 cites·5 claims
- 0670US8158799B2Hydroxyquinoline derivativesSCHADT OLIVER·Filed 2006·Granted Apr 17, 2012·1 cites·16 claims
- 0769US6924357B2Lipid binding protein 4MERCK PATENT GMBH·Filed 2001·Granted Aug 2, 2005·2 cites·10 claims
- 0864US2009035270A1COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alphaGRELL MATTHIAS·Filed 2007·Application pending·0 cites
- 0956US2009163556A1Glycinamide derivatives as raf-kinase inhbitorsBUCHSTALLER HANS-PETER·Filed 2008·Application pending·0 cites
- 1055US2013158076A1Methylene Urea DerivativesMERCK PATENT GMBH·Filed 2013·Application pending·0 cites
- 1154US2009130098A1Specific therapy using integrin ligands for treating cancerMERCK PATENT GMBH·Filed 2007·Application pending·0 cites
- 1254US2011177027A1COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalphaGRELL MATTHIAS·Filed 2011·Application pending·0 cites
- 1353US2004136949A1Combination therapy using anti-angiogenic agents and tnf alphaGRELL MATTHIAS·Filed 2002·Application pending·0 cites
- 1451US7476683B2Glycinamide derivatives as raf-kinase inhibitorsMERCK PATENT GMBH·Filed 2003·Granted Jan 13, 2009·0 cites·26 claims
- 1550US2005014769A1Use of endothelin receptor antogonists for the treatment of tumour diseasesFiled 2002·Application pending·0 cites
- 1647US7691886B2Benzimidazole derivatives as raf kinase inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Apr 6, 2010·0 cites·9 claims
- 1746US2007213374A1Malonamide DerivativesMERCK PATENT GMBH·Filed 2004·Application pending·0 cites
- 1846US2006189665A1Oxamide derivatives useful as raf-kinase inhibitorsMERCK PATENT GMBH·Filed 2004·Application pending·0 cites
- 1942US2011165150A1Isolated organ perfusion combination therapy of cancerMERCK PATENT GMBH·Filed 2006·Application pending·0 cites
- 2041US2007191423A1Isoquinoline derivativesMERCK PATENT GMBH·Filed 2005·Application pending·0 cites
- 2141US2006216750A1New lipid binding protein 1GRELL MATTHIAS·Filed 2005·Application pending·0 cites
- 2241US2007093529A1Diacylhydrazine derivativesFINSINGER DIRK·Filed 2004·Application pending·0 cites
- 2341US2009253688A1Semicarbazide derivatives as kinase inhibitorsMERCK PATENT GMBH·Filed 2005·Application pending·0 cites
- 2440US2005107592A1Lipid binding protein 1Filed 2001·Application pending·0 cites
- 2539US2003139573A1Lipid binding protein 3Filed 2001·Application pending·0 cites
- 2639US2007191444A1Benzimidazolyl derivativesBUCHSTALLER HANS-PETER·Filed 2005·Application pending·0 cites
- 2737US2007142440A1Pyridinamide derivatives as kinase inhibitorsBURGDORF LARS·Filed 2005·Application pending·0 cites
- 2837US2007191353A1Use of thiadiazoleurea derivativesBURGDORF LARS·Filed 2005·Application pending·0 cites
- 2934US2003143654A1F-box containing proteinFiled 2001·Application pending·0 cites
- 3032US2004053829A1Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrugFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →